ENTITY
Haw Par Corp

Haw Par Corp (HPAR SP)

44
Analysis
Health CareSingapore
Haw Par Corporation Limited is an investment holding company whose subsidiaries manufacture, market, and trade healthcare products under the Tiger and Kwan Loong brand names. The Company also manufactures dietary supplements and pharmaceuticals, and operates recreational centers. Haw Par invests in properties and securities.
more
bullishHaw Par Corp
01 Mar 2018 08:00Issuer-paid

Slow Quarter

For the fourth quarter ended December 2017, Haw Par reported revenue of SG$48 mn, up 2.2% YoY. Gross profit increased by 3.9% YoY to 30.6 mn while...

Logo
98 Views
Share
bullishHaw Par Corp
13 Nov 2017 16:28Issuer-paid

Q3FY2017 [ended September] Earnings Update

-4.4% EPS & +7.4% Revenue Growth Haw Par reported revenue of SG$53.4 mn for 3Q2017, growth of 7.4% YoY, driven by strong sales in the...

Logo
111 Views
Share
bullishHaw Par Corp
14 Aug 2017 08:00Issuer-paid

Q2 FY2017: +6.8% EPS & +15% Revenue Growth

Haw Par reported another quarter of strong performance driven by solid healthcare segment sales partially offset by lower sales from the leisure...

Logo
102 Views
Share
bullishHaw Par Corp
27 Feb 2017 08:00Issuer-paid

Healthcare Segment Drives Revenue Beat

Haw Par reported strong results for the fourth quarter ended December 31, 2016 beating our revenue estimate by 15%. Revenue grew by 38% during the...

Logo
192 Views
Share
bullishHaw Par Corp
14 Nov 2016 08:00Issuer-paid

Haw Par Corp: 3QFY2016 Earnings Update

Revenue for 3Q 2016 increased 3.3% YoY to SG$ 49.7 million as compared to SG$ 48.1 million during 3Q 2015. The increase in revenue came on the back...

Logo
147 Views
Share
x